Target intelligence / Profile preview

Helicobacter pylori cell wall (null)

Target
null
Molecular classification
Other (cell wall structure), Enzyme (for the PG biosynthesis and modifying enzymes within the wall, e.g., penicillin binding proteins, PG hydrolases), Structural component (peptidoglycan)
01

Overview

The Helicobacter pylori cell wall is a **peptidoglycan-based structure** that defines the bacterium’s helical shape and is critical for its ability to colonize the stomach. The PG cell wall consists of alternating *N*-acetylglucosamine and *N*-acetylmuramic acid residues crosslinked via peptide stems, forming a mesh that resists turgor pressure and contributes to motility and pathogenicity[1][7][10]. Specialized cytoskeletal and membrane-associated proteins, including CcmA, Csd5, and PG-modifying enzymes, regulate wall remodeling, maintaining helical morphology vital for gastric colonization[1][4][10]. Targeting enzymes responsible for cell wall biosynthesis and modification has enabled successful antibiotic therapies; however, resistance and drug permeability remain therapeutic challenges[3][6][9]. The specificity of the bacterial cell wall makes it an attractive target with reduced risk of human toxicity[6], and ongoing research seeks new inhibitors effective against resistant *H. pylori* strains[3][6][9].

Other names
Peptidoglycan cell wall of Helicobacter pyloriH. pylori PG cell wallHelicobacter pylori sacculus
02

Mechanism of action

Inhibiting peptidoglycan synthesis via targeting PBPs or biosynthetic enzymes (bactericidal action) Disrupting cell wall integrity leading to loss of shape and cell death Targeting regulatory pathways for cell wall remodeling

03

Biological functions

Maintains bacterial cell shape and helical morphologyProtects against osmotic pressure and environmental stressFacilitates colonization by conferring motility and niche adaptation
04

Disease associations

Infection (critical for survival and pathogenicity of *H. pylori* in the gastric environment)Cancer (implicated indirectly via persistent infection leading to gastric cancer)
05

Safety considerations

Off-target toxicity is generally low due to absence of PG cell wall biosynthetic pathways in humansEmergence of antibiotic resistance due to cell wall-modifying enzyme mutationsChallenge of drug penetration due to complex Gram-negative envelope
06

Interacting drugs

Clarithromycin

4 more in the full profile.

07

Biomarkers

Peptidoglycan composition and structure (unique muropeptide content, detectable via biochemical methods)Cell wall remodeling enzymes or their expression patterns (e.g., Csd1, Csd3, CcmA)

Beyond the preview

Go deeper on Helicobacter pylori cell wall (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori cell wall (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call